Canada Post Corp Registered Pension Plan Acquires 12,130 Shares of CVS Health Corporation $CVS

Key Points

• Canada Post Corp Registered Pension Plan increased its CVS Health stake by 53.3% in Q4, buying 12,130 additional shares and bringing its total holding to 34,903 shares worth about $2.77 million.
• CVS Health has seen broad institutional buying, with several hedge funds and pension plans adding to positions; institutional investors now own 80.66% of the company.
• Analysts remain generally positive on CVS, with 22 Buy ratings and 4 Hold ratings, while the company also reported better-than-expected Q1 earnings and raised its FY 2026 EPS guidance to $7.30-$7.50.

Canada Post Corp Registered Pension Plan raised its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 53.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 34,903 shares of the pharmacy operator's stock after purchasing an additional 12,130 shares during the period. Canada Post Corp Registered Pension Plan's holdings in CVS Health were worth $2,770,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. National Pension Service boosted its holdings in shares of CVS Health by 3.1% during the 3rd quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator's stock worth $301,532,000 after purchasing an additional 119,189 shares during the last quarter. Kingsview Wealth Management LLC boosted its holdings in shares of CVS Health by 316.2% during the 3rd quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator's stock worth $7,873,000 after purchasing an additional 79,340 shares during the last quarter. AE Wealth Management LLC boosted its holdings in shares of CVS Health by 6.2% during the 3rd quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator's stock worth $19,391,000 after purchasing an additional 14,983 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in CVS Health by 11.2% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator's stock valued at $16,971,000 after acquiring an additional 22,653 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its holdings in CVS Health by 186.6% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator's stock valued at $30,568,000 after acquiring an additional 258,050 shares during the last quarter. Institutional investors own 80.66% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently commented on CVS. The Goldman Sachs Group upped their price objective on CVS Health from $95.00 to $97.00 and gave the company a "buy" rating in a report on Thursday, February 12th. HSBC upped their price objective on CVS Health from $83.00 to $85.00 and gave the company a "hold" rating in a report on Tuesday, May 5th. Piper Sandler decreased their price objective on CVS Health from $101.00 to $99.00 and set an "overweight" rating on the stock in a report on Tuesday, March 31st. Deutsche Bank Aktiengesellschaft upped their price objective on CVS Health from $88.00 to $92.00 and gave the company a "buy" rating in a report on Thursday, May 7th. Finally, JPMorgan Chase & Co. upped their price objective on CVS Health from $101.00 to $111.00 and gave the company an "overweight" rating in a report on Tuesday, May 12th. Twenty-two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $98.08.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Morgan Stanley raised its price target on CVS Health and kept an overweight rating, signaling confidence in further upside after the company’s stronger-than-expected quarterly results. Morgan Stanley Issues Positive Forecast for CVS Health NYSE: CVS Stock Price
• Positive Sentiment: Argus also lifted its outlook for CVS Health, adding to the wave of analyst support that may be helping shares move higher. Argus Issues Positive Forecast for CVS Health NYSE: CVS Stock Price
• Positive Sentiment: CVS reported solid Q1 2026 earnings recently, beating estimates on both revenue and adjusted EPS, which continues to drive investor optimism about execution and valuation. Here is Why CVS Health (CVS) is One of the Cheap Stocks to Buy For the Next 10 Years
• Positive Sentiment: CVS and WGU launched an online pre-pharmacy degree program to help build a stronger pharmacist pipeline, a move that could support long-term staffing and service growth. CVS Health® and WGU launch online pre-pharmacy degree program for future pharmacists nationwide
• Neutral Sentiment: CVS advanced its portfolio reset by selling Omnicare after bankruptcy court approval, which simplifies the business and removes an underperforming unit, but also confirms ongoing restructuring. CVS Refocuses On Core Health Platform With Omnicare Sale And Drone Rollout
• Neutral Sentiment: CVS also highlighted community and brand-building initiatives in Rhode Island, including its economic impact report and expanded WIC acceptance, which are positive for reputation but less likely to move the stock on their own. CVS Health’s Annual Impact in Rhode Island

CVS Health Stock Performance

NYSE:CVS opened at $95.95 on Monday. The firm has a market capitalization of $122.42 billion, a PE ratio of 42.27, a price-to-earnings-growth ratio of 0.94 and a beta of 0.60. The business's fifty day moving average price is $78.71 and its 200 day moving average price is $78.57. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a 12 month low of $58.50 and a 12 month high of $98.43.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, beating the consensus estimate of $2.21 by $0.36. The firm had revenue of $100.43 billion for the quarter, compared to analyst estimates of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.CVS Health's revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.25 earnings per share. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, sell-side analysts anticipate that CVS Health Corporation will post 7.44 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, May 4th. Investors of record on Thursday, April 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, April 23rd. CVS Health's dividend payout ratio is 117.18%.

Insider Buying and Selling

In related news, EVP Tilak Mandadi sold 69,551 shares of the stock in a transaction on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the transaction, the executive vice president owned 10,133 shares of the company's stock, valued at $907,714.14. This represents a 87.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 0.85% of the stock is owned by company insiders.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.